Genenta Science SpA ADR (GNTA) Stock Price

Genenta Science SpA ADR Price

NYSE·CLOSED
0.62
​
Market closed

Genenta Science SpA ADR stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genenta Science SpA ADR business model & stock analysis

Genenta Science S.p.A. generates value by developing hematopoietic stem cell gene therapies for solid tumors in Italy. The company focuses on its product Temferon, which is currently in Phase 1/2a clinical trials for the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. Additionally, the firm is expanding the application of Temferon to other solid tumor indications. The business model relies on a proprietary biologic platform designed to deliver immunomodulatory molecules directly to tumors by infiltrating monocytes and macrophages. As a clinical-stage biotechnology company incorporated in 2014 and headquartered in Milan, Italy, Genenta Science S.p.A. utilizes this platform to advance its therapeutic pipeline and address unmet medical needs in oncology.

Frequently asked questions about Genenta Science SpA ADR

7 analysts currently rate the Genenta Science SpA ADR stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Genenta Science SpA ADR share trades at 0.55 EUR (0.62 USD).

The revenue cannot currently be calculated for Genenta Science SpA ADR.

The expected profit of Genenta Science SpA ADR is -10.85 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Genenta Science SpA ADR is currently -1.33. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Genenta Science SpA ADR stock.

The P/S cannot be calculated for Genenta Science SpA ADR currently.

The Eulerpool Quality Score for Genenta Science SpA ADR is 2/10.

The ISIN of Genenta Science SpA ADR is US36870W1009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Genenta Science SpA ADR is GNTA. The ticker symbol is used to trade Genenta Science SpA ADR shares on the stock exchange.

Fair ValueTerminal
0.52 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website genenta.com
Currency
USD
Initial public offering
Dec 15, 2021
ISIN
US36870W1009
Cusip
36870W100
Market capitalization
14.58 M USDMicro Cap
52-Week Range
PEG
0.09
P/E ratio
P/Ee 2026
-1.33
P/Ee 2027
-1.16
P/Ee 2028
-2.93
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.60
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-21.30 %
Last updated Oct 30, 2026, 4:29 AM

Genenta Science SpA ADR Peer Group